Research Topics
| Gaetano VattemiSummaryAffiliation: University of Verona Country: Italy Publications
|
Detail Information
Publications
Brody disease: insights into biochemical features of SERCA1 and identification of a novel mutationGaetano Vattemi
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Verona, Italy
J Neuropathol Exp Neurol 69:246-52. 2010..In addition, we describe 2 novel mutations in the ATP2A1 gene...
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathyG Vattemi
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Italy
Acta Myol 30:121-6. 2011....
SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathyGiuliano Tomelleri
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Verona, Italy
Brain 129:2085-92. 2006..Our cases, both sporadic and familial, represent a new type of surplus protein myopathy...
Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotypeMassimiliano Filosto
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Italy
Neuromuscul Disord 18:204-9. 2008..This is the first reported case of mitochondrial myopathy/facioscapulohumeral muscular dystrophy (FSHD) "double trouble"...
Selective pseudohypertrophy of vastus medialis muscles associated with calpain 3 deficiencyGaetano Vattemi
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Verona, Italy
Neurologist 18:306-9. 2012..Nevertheless, calpainopathy is not always associated with mutations in the specific gene and secondary reduction in protein expression has been described...
Endothelial dysfunction and increased oxidative stress in mitochondrial diseasesPietro Minuz
Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy
Clin Sci (Lond) 122:289-97. 2012..58±0.30%), thus abolishing the differences between patients and controls. The results of the present study indicate that oxidative stress is increased and is, at least partly, responsible for endothelial dysfunction in MDs...
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvementGaetano Vattemi
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Italy
Mol Cell Proteomics 10:M110.002964. 2011..The present results provide evidence that in MD the vessel wall is a target of increased oxidative/nitrative stress...
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseasesMassimiliano Filosto
Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Policlinico G.B. Rossi, P. le L.A. Scuro 10, 37134 Verona, Italy
Acta Neuropathol (Berl) 103:215-20. 2002..In addition, we suggest that expression of MnSOD and GSH may be considered an initial, indirect sign of respiratory chain dysfunction because it is observed in the early stages of the disease...
